Literature DB >> 11895775

Human single chain antibodies against heparin: selection, characterization, and effect on coagulation.

Els M A van de Westerlo1, Toon F C M Smetsers, Michel A B A Dennissen, Robert J Linhardt, Jacques H Veerkamp, Goos N P van Muijen, Toin H van Kuppevelt.   

Abstract

Heparin, located in mast cells and basophilic granulocytes, is widely used as an anticoagulant. It belongs to a class of linear polysaccharides called glycosaminoglycans (GAGs). Using phage display technology, we have selected 19 unique human antiheparin antibodies. Some antibodies react almost exclusively with heparin, others also react with the structurally related heparan sulfate, and some with chondroitin sulfate. In all cases, sulfate groups are essential for binding. For activity of some antibodies, O-sulfation is more important than N-sulfation. Antibodies are reactive with heparin in mast cells. Each antibody showed a defined staining pattern on cryosections of rat kidney, pancreas, and testis. Enzymatic digestion with glycosidases on tissue sections further indicated that the antibodies are specific for GAGs. All antibodies recognize a unique epitope. The effect of the antibodies on heparin as an anticoagulant was also studied. There were 3 antibodies that were very effective inhibitors of heparin action in the activated partial thromboplastin time (APTT) clotting assay, and their effect was related to the amount of heparin bound. Some antibodies reacted strongly with the pentasaccharide, which interacts with antithrombin III. The human antibodies selected represent unique tools to study the structure, location, and function of heparin and related GAGs, and some may be used as blocking agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895775     DOI: 10.1182/blood.v99.7.2427

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  Peptide-displaying phage technology in glycobiology.

Authors:  Michiko N Fukuda
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

2.  A transgenic approach to live imaging of heparan sulfate modification patterns.

Authors:  Matthew Attreed; Hannes E Bülow
Journal:  Methods Mol Biol       Date:  2015

3.  Imaging Glycosaminoglycan Modification Patterns In Vivo.

Authors:  Hannes E Bülow
Journal:  Methods Mol Biol       Date:  2022

4.  A glycan-based approach to cell characterization and isolation: Hematopoiesis as a paradigm.

Authors:  Richard T Piszczatowski; Emily Schwenger; Sriram Sundaravel; Catarina M Stein; Yang Liu; Pamela Stanley; Amit Verma; Deyou Zheng; Ronald D Seidel; Steven C Almo; Robert A Townley; Hannes E Bülow; Ulrich Steidl
Journal:  J Exp Med       Date:  2022-09-06       Impact factor: 17.579

5.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

6.  Conservation of anatomically restricted glycosaminoglycan structures in divergent nematode species.

Authors:  Matthew Attreed; Kristian Saied-Santiago; Hannes E Bülow
Journal:  Glycobiology       Date:  2016-03-13       Impact factor: 4.313

7.  Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.

Authors:  T J M Wijnhoven; M J W van den Hoven; H Ding; T H van Kuppevelt; J van der Vlag; J H M Berden; R A Prinz; E J Lewis; M Schwartz; X Xu
Journal:  Diabetologia       Date:  2007-12-06       Impact factor: 10.122

8.  Direct visualization of specifically modified extracellular glycans in living animals.

Authors:  Matthew Attreed; Muriel Desbois; Toin H van Kuppevelt; Hannes E Bülow
Journal:  Nat Methods       Date:  2012-04-01       Impact factor: 28.547

9.  Characterization of anticoagulant heparinoids by immunoprofiling.

Authors:  Tessa J Wijnhoven; Els M van de Westerlo; Nicole C Smits; Joost F Lensen; Angelique L Rops; Johan van der Vlag; Jo H Berden; Lambert P van den Heuvel; Toin H van Kuppevelt
Journal:  Glycoconj J       Date:  2007-10-02       Impact factor: 2.916

10.  Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate.

Authors:  Wei Gao; Yongmei Xu; Jian Liu; Mitchell Ho
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.